<DOC>
	<DOCNO>NCT00403949</DOCNO>
	<brief_summary>The purpose study test efficacy safety AzA 15 % Gel treatment mild moderate perioral dermatitis .</brief_summary>
	<brief_title>A Study Azelaic Acid ( AzA ) 15 % Topical Treatment Mild Moderate Perioral Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Perioral</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Clinical diagnosis mild moderate perioral dermatitis diagnose physician Investigator 's Global Assessment ( IGA ) score baseline 2 3 ( scale 0 4 ) 8 50 facial inflammatory lesion ( papule , papulopustules , papulovesicle ) History atopic dermatitis face Granulomatous perioral dermatitis Facial acne , rosacea , facial demodicosis Seborrheic dermatitis nasolabial fold , Lupus erythematosus The use topical systemic medication could affect course treatment and/or evaluation Severe diseases likely interfere conduct / plan termination study ( e.g . cancer , cardiac infarct , unstable angina pectoris , uncontrolled diabetes ) Use fluorinated toothpaste Planned exposure artificial intensive natural UV light test area throughout course study Use / plan use cosmetic product ( e.g . cream , moisturizers , makeup , fatty lipstick ) test area course study History suspect hypersensitivity ingredient study drug Participation another clinical study 4 week prior and/or conduct study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>